U.S., Nov. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07253688) titled 'Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus' on Nov. 19.
Brief Summary: This is a sub-study of the S. aureus Network Adaptive Platform (SNAP) trial (NCT05137119) wherein we will evaluate whether not giving rifampin in patients with probable or definite prosthetic valve endocarditis due to S. aureus is non-inferior to giving rifampin.
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Staphylococcus Aureus Endocarditis
Prosthetic Valve Endocarditis
Intervention:
DRUG: Rifampin
Patients will receive rifampin 900mg a day in 2-3 divided doses
OTHER: No rifampin
Subject...